Novo Nordisk Falls, Praxis Precision Rallies, Lululemon Rises
On this episode of Stock Movers:- Novo Nordisk (NVO) cut the price of its obesity drug Wegovy in China as the Danish drugmaker gears up for a potential flood of copycats. The reduction will “help alleviate the treatment burden for patients and improve their quality of life,” a spokesperson said by email. The list prices for the two highest dosages of Wegovy were cut by half in some Chinese provinces, local media Yicai reported on Monday, citing drug-procurement documents for southwestern Chinese provinces Yunnan and Sichuan. Shares of Novo Nordisk slipped.- Praxis Precision (PRAX)…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.